¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
»ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°è »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö 12.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÏ¿© 2030³â¿¡´Â 39¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â »ê¼Ò º¸Á¸ ÀåÄ¡ÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°è õ½Ä ³×Æ®¿öÅ©¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î ¾à 3¾ï 3,400¸¸ ¸íÀÌ Ãµ½ÄÀ» ¾Î°í ÀÖ½À´Ï´Ù. ÀÌ´Â ÇâÈÄ ¸î ³âµ¿¾È ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ÀáÀçÀûÀÎ ¼ö¿ä¸¦ º¸¿©ÁÝ´Ï´Ù.
WHO¿¡ µû¸£¸é, COPD ¹× ±âŸ È£Èí±â ÁúȯÀÇ ¹ßº´·ü Áõ°¡´Â »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ÀÌ·¯ÇÑ Á¦Ç°ÀÇ Ã¤ÅÃÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ½Ç³»¿Ü ¿À¿° Áõ°¡¿Í »ýȰ½À°ü º¯È µîÀÇ ¿äÀÎÀÌ Ãµ½Ä ¹ßº´·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ¼ö¿ä Áõ°¡¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
»ê¼Ò ³¶ºñ °¨¼Ò, »ç¿ë ÆíÀǼº, È޴뼺 Çâ»ó, ȯÀÚ Á¢±Ù¼º Çâ»ó µîÀÇ ÀáÀçÀû ÀÌÁ¡À» °®Ãá ±â¼úÀûÀ¸·Î Áøº¸µÈ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, Àß Â¥¿©Áø »óȯ ±¸Á¶¿Í Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ¸ÞµðÄɾî Á¤Ã¥Àº ÀÇ·á Àü¹®°¡°¡ ó¹æÇÑ °æ¿ì »ê¼Ò Ä¡·á Àåºñ¿¡ ´ëÇÑ È¯±ÞÀ» Çã¿ëÇϰí ÀÖ½À´Ï´Ù.
»ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- 2023³â ½ÃÀå Á¡À¯À²Àº Àú¼öÁöÇü »ê¼Ò °ø±Þ ÀåÄ¡°¡ 33.6%·Î 1À§¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº Ãʱ⠵µÀÔ°ú ȯÀÚ ¹× º´¿ø¿¡¼ÀÇ ³ôÀº äÅ÷ü¿¡ ±âÀÎÇÕ´Ï´Ù.
- Àü±â ±â°è½Ä ÆÞ½º ÀåÄ¡´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 12.2%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¼úÀû Ÿ´ç¼ºÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ÀåÄ¡´Â ȯÀÚÀÇ À̵¿¼ºÀ» ³ôÀ̰í O2 À¯·®À» À¯ÁöÇÕ´Ï´Ù.
- ÀçÅÃÄ¡·á ºÎ¹®Àº 2023³â 41.7%ÀÇ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀçÅÃÄ¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ ȯÀÚÀÇ Æí¾ÈÇÔÀ» ÃËÁøÇÏ°í º´¿ø °ü·Ã ºñ¿ëÀ» Àý°¨ÇÒ Çʿ䰡 ÀÖÀ¸¸ç, °¨¿°¿¡ ´ëÇÑ µÎ·Á¿òÀÌ ÀÌ·¯ÇÑ Ãß¼¼¸¦ °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù.
- Àå±â¿ä¾ç½Ã¼³ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È 12.2%ÀÇ °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°è Àα¸ Åë°èÇÐÀû º¯È·Î ÀÎÇØ °í±Þ »ý¸í À¯Áö Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Àå±â ¿ä¾ç ½Ã¼³¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
- ºÏ¹Ì°¡ 2023³â 34.5%·Î °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¼¼°è ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Àß Á¤ºñµÈ 1Â÷, 2Â÷, 3Â÷ º´¿øÀÇ Á¸Àç°¡ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀåÀº ÀÇ·á ºñ¿ë¿¡ ´ëÇÑ ÅõÀÚ°¡ Å©°Ô Áõ°¡ÇÔ¿¡ µû¶ó Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
- ´ë±â¾÷µéÀº ½ÃÀå ÁöÀ§¸¦ À¯ÁöÇϱâ À§ÇØ ÀμöÇÕº´(M&A) µî ´Ù¾çÇÑ Àü·«À» ±¸»çÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2017³â 9¿ù ¿¡¾î¸®Äûµå´Â ÀϺ» ÀçÅÃÀÇ·á ¹× ÀÇ·á¿ë °¡½º »ç¾÷À» È®´ëÇϱâ À§ÇØ Á¾ÇÕ»ê¾÷ÁÖ½Äȸ»ç¸¦ ÀμöÇß½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå ¼·Ð/°èÅë Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå ºÐ¼® Åø
- PorterÀÇ Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- ¸®Àú¹ö »ê¼Ò °ø±Þ ÀåÄ¡
- Àü±â±â°è½Ä ÆÞ½º ¹ß»ý ÀåÄ¡
- °æ±â°ü Ä«Å×ÅÍ
- ±âŸ
Á¦5Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- º´¿ø ¹× Ŭ¸®´Ð
- Àå±â Äɾî À¯´Ö
- ȨÄɾî
Á¦6Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå Á¡À¯À², Áö¿ªº°, 2023³â ¹× 2030³â
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦7Àå °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ±â¾÷ ºÐ·ù
- ±â¾÷ È÷Æ®¸Ê ºÐ¼®
- ±â¾÷ °³¿ä
- Invacare Corporation
- Philips Respironics
- Chart Industries
- GF Health Products, Inc.
- Drive DeVilbiss Healthcare
- Inogen, Inc.
- Precision Medical, Inc
- CAIRE Inc.(Chart Industries)
- Teleflex Incorporated
LSH 24.10.30
Oxygen Conservation Devices Market Growth & Trends:
The global oxygen conservation devices market size is expected to reach USD 3.95 billion by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of respiratory diseases is expected to boost the adoption of oxygen conservation devices. According to the Global Asthma Network, nearly 334 million people are affected by asthma worldwide. This shows the potential demand for these devices in the coming years.
According to the WHO, rise in the incidence of COPD and other respiratory disorders is anticipated to boost the demand for oxygen therapy and consequentially increase the adoption of these products. Furthermore, factors such as increasing indoor & outdoor pollution and changing lifestyle contribute to the rising incidence of asthma, thereby fueling demand over the forecast period.
Growing demand for technologically advanced products with potential benefits such as less O2 wastage, ease of use, increased portability, and enhanced patient response are among factors expected to generate lucrative growth opportunities. In addition, well-developed reimbursement structure and supportive regulatory framework are propelling the market. For instance, Medicare policies in the U.S. offer reimbursement for oxygen therapy equipment when it is prescribed by a healthcare professional.
Oxygen Conservation Devices Market Report Highlights:
- Reservoir oxygen delivery devices accounted for a leading market share of 33.6% in 2023. The growth depends on their early introduction and high adoption rate among patients and hospitals.
- Electromechanical pulsing devices are expected to register the fastest CAGR of 12.2% over the forecast period. Due to their technological feasibility, these devices enhance patient mobility and preserve O2 flow.
- The home care segment dominated the market with a share of 41.7% in 2023. The increasing preference for home health care drives patient comfort, the need to reduce hospital-related costs, and the fear of infection accelerates the trend.
- The long-term care unit segment is projected to grow at the fastest CAGR of 12.2 % over the forecast period. The global demographic shift towards advanced life-saving devices drives the demand for long-term care facilities.
- North America dominated the global market and accounted for the largest revenue share, 34.5%, in 2023. The availability of well-developed primary, secondary, and tertiary hospitals supports market growth in the region.
- Asia Pacific oxygen conservation devices market is anticipated to witness significant growth due to the significantly increasing investments in healthcare expenditures.
- Major players are involved in various strategies such as mergers & acquisitions to sustain their market position. For instance, in September 2017, Air Liquide acquired Sogo Sangyo Kabushiki Kaisha, thereby increasing its home healthcare and medical gases business in Japan
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Oxygen Conservation Devices Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Oxygen conservation devices Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining Power of the Suppliers
- 3.4.1.2. Bargaining Power of the Buyers
- 3.4.1.3. Threats of Substitution
- 3.4.1.4. Threats From New Entrants
- 3.4.1.5. Competitive Rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political Landscape
- 3.4.2.2. Economic and Social Landscape
- 3.4.2.3. Technological Landscape
- 3.4.2.4. Environmental Landscape
- 3.4.2.5. Legal Landscape
Chapter 4. Oxygen conservation devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Oxygen Conservation Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Reservoir Oxygen Delivery Devices
- 4.3.1. Reservoir Oxygen Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Electromechanical Pulsing Devices
- 4.4.1. Electromechanical Pulsing Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Transtracheal Catheters
- 4.5.1. Transtracheal Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Oxygen Conservation Devices Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Oxygen Conservation Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Hospitals & Clinics
- 5.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Long-term Care Units
- 5.4.1. Long-term Care Units Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Home Care
- 5.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Oxygen Conservation Devices Market: Regional Estimates & Trend Analysis
- 6.1. Oxygen Conservation Devices Market Share, By Region, 2023 & 2030 (USD Million)
- 6.2. North America
- 6.2.1. North America Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. U.S. Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Canada Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
- 6.3.2.1. UK Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Germany Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. France Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Spain Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. China
- 6.4.2.1. China Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Japan
- 6.4.3.1. Japan Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
- 6.4.4.1. India Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
- 6.4.5.1. South Korea Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. Australia
- 6.4.6.1. Australia Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Brazil Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
- 6.6.2.1. South Africa Oxygen Conservation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis by Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. Invacare Corporation
- 7.4.1.1. Participant's Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Philips Respironics
- 7.4.2.1. Participant's Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Chart Industries
- 7.4.3.1. Participant's Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. GF Health Products, Inc.
- 7.4.4.1. Participant's Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Drive DeVilbiss Healthcare
- 7.4.5.1. Participant's Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Inogen, Inc.
- 7.4.6.1. Participant's Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Precision Medical, Inc
- 7.4.7.1. Participant's Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. CAIRE Inc. (Chart Industries)
- 7.4.8.1. Participant's Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Teleflex Incorporated
- 7.4.9.1. Participant's Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Recent Developments/ Strategic Initiatives